InvestorsHub Logo
Followers 3156
Posts 962760
Boards Moderated 187
Alias Born 09/04/2000

Re: mick post# 143

Wednesday, 08/31/2022 6:26:54 PM

Wednesday, August 31, 2022 6:26:54 PM

Post# of 179
CureVac (CVAC) Receives a Buy from Berenberg Bank
August 23 2022 - 09:55PM
Share On Facebook
In a report released yesterday, Zhiqiang Shu from Berenberg Bank maintained a Buy rating on CureVac (CVAC - Research Report), with a price target of $45.00. The company's shares closed yesterday at $11.32.Shu covers the Healthcare sector, focusing on stocks such as Alnylam Pharma, Arcus Biosciences, and Sutro Biopharma. According to TipRanks, Shu has an average return of -21.0% and a 23.78% success rate on recommended stocks. Currently, the analyst consensus on CureVac is a Moderate Buy with an average price target of $28.50, implying a 151.77% upside from current levels.
Day Range:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVAC News